UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

The GIRK2 subunit is involved in IS‐like seizures induced by GABAB receptor agonists

Epilepsia (Copenhagen), 2015-07, Vol.56 (7), p.1081-1087

2015

Volltextzugriff (PDF)

Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model

Alzheimer's & dementia, 2021-02, Vol.17 (2), p.271-292

2021

Volltextzugriff (PDF)

Ultrasonic vocalization phenotypes in the Ts65Dn and Dp(16)1Yey mouse models of Down syndrome

Physiology & behavior, 2023-11, Vol.271, p.114323-114323, Article 114323

2023

Volltextzugriff (PDF)

A protocol for quantitative analysis of murine and human amyloid-β1-40 and 1-42

Journal of neuroscience methods, 2017-11, Vol.291, p.28-35

2017

Volltextzugriff (PDF)

Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome

Neuron (Cambridge, Mass.), 2020-12, Vol.108 (5), p.887-904.e12

2020

Volltextzugriff (PDF)

The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted

Biological psychiatry (1969), 2023-07, Vol.94 (1), p.84-97

2023

Volltextzugriff (PDF)

Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome

Neural regeneration research, 2019-04, Vol.14 (4), p.613-620

2019

Volltextzugriff (PDF)

Down syndrome and Alzheimer's disease: Common pathways, common goals

Alzheimer's & dementia, 2015-06, Vol.11 (6), p.700-709

2015

Volltextzugriff (PDF)

Postnatal environmental enrichment enhances memory through distinct neural mechanisms in healthy and trisomic female mice

Neurobiology of disease, 2022-10, Vol.173, p.105841-105841, Article 105841

2022

Volltextzugriff (PDF)

Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

Frontiers in aging neuroscience, 2024-05, Vol.16, p.1401109-1401109

2024

Volltextzugriff (PDF)

Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome

Neurobiology of disease, 2020-07, Vol.140, p.104874-104874, Article 104874

2020

Volltextzugriff (PDF)

Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes

Neurobiology of disease, 2017-10, Vol.106, p.76-88

2017

Volltextzugriff (PDF)

Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome

Disease models & mechanisms, 2018-06, Vol.11 (6)

2018

Volltextzugriff (PDF)

Altered tongue muscle contractile properties coincide with altered swallow function in the adult Ts65Dn mouse model of down syndrome

Frontiers in neurology, 2024, Vol.15, p.1384572-1384572

2024

Volltextzugriff (PDF)

Hyper-Rigid Phasic Organization of Hippocampal Activity But Normal Spatial Properties of CA1 Place Cells in the Ts65Dn Mouse Model of Down Syndrome

The Journal of neuroscience, 2022-02, Vol.42 (8), p.1542-1556

2022

Volltextzugriff (PDF)

Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome

Neurochemistry international, 2024-03, Vol.174, p.105679-105679, Article 105679

2024

Volltextzugriff (PDF)

Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of Down syndrome

Nutritional neuroscience, 2022-07, Vol.25 (7), p.1400-1412

2022

Volltextzugriff (PDF)

Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome

eLife, 2020-08, Vol.9

2020

Volltextzugriff (PDF)

Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome

Hippocampus, 2021-04, Vol.31 (4), p.435-447

2021

Volltextzugriff (PDF)

Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down Syndrome

Investigative ophthalmology & visual science, 2020-05, Vol.61 (5), p.25-25

2020

Volltextzugriff (PDF)

Temporal and brain region‐specific elevations of soluble Amyloid‐β40‐42 in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease

Aging cell, 2022-04, Vol.21 (4), p.e13590-n/a

2022

Volltextzugriff (PDF)

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome

Glia, 2020-07, Vol.68 (7), p.1347-1360

2020

Volltextzugriff (PDF)

Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome

Developmental neuroscience, 2022-02, Vol.44 (1), p.23-38

2022

Volltextzugriff (PDF)

Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model

Molecular and cellular neuroscience, 2022-03, Vol.119, p.103705-103705, Article 103705

2022

Volltextzugriff (PDF)

Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome

Brain research, 2021-09, Vol.1766, p.147535-147535, Article 147535

2021

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(197)

Publikationsform

Artikel
(216)
Buchkapitel
(5)
Texte
(1)

Sprache

Englisch
(222)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The GIRK2 subunit is involved in IS‐like seizures induced by GABAB receptor agonists

Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model

Ultrasonic vocalization phenotypes in the Ts65Dn and Dp(16)1Yey mouse models of Down syndrome

A protocol for quantitative analysis of murine and human amyloid-β1-40 and 1-42

Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome

The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted

Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome

Down syndrome and Alzheimer's disease: Common pathways, common goals

Postnatal environmental enrichment enhances memory through distinct neural mechanisms in healthy and trisomic female mice

Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome

Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes

Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome

Altered tongue muscle contractile properties coincide with altered swallow function in the adult Ts65Dn mouse model of down syndrome

Hyper-Rigid Phasic Organization of Hippocampal Activity But Normal Spatial Properties of CA1 Place Cells in the Ts65Dn Mouse Model of Down Syndrome

Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome

Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of Down syndrome

Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome

Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome

Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down Syndrome

Temporal and brain region‐specific elevations of soluble Amyloid‐β40‐42 in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome

Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome

Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model

Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome

Suchergebnisse filtern